Initiator Pharma A/S (STO:INIT)
Sweden · Delayed Price · Currency is SEK 2.160
-0.030 (-1.37%)
Sep 22, 2026, 5:12 PM CET
Initiator Pharma Market Cap
Initiator Pharma has a market cap or net worth of 147.86 million as of September 22, 2026. Its market cap has decreased by -38.98% in one year.
Market Cap
147.86M
Enterprise Value
136.90M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.16
ChartMarket Cap Chart
Since March 16, 2017, Initiator Pharma's market cap has increased from 50.37M to 147.86M, an increase of 193.56%. That is a compound annual growth rate of 11.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 147.86M | -27.03% |
| Dec 30, 2025 | 202.62M | -47.31% |
| Dec 30, 2024 | 384.53M | -20.69% |
| Dec 29, 2023 | 484.84M | 52.80% |
| Dec 30, 2022 | 317.31M | -10.94% |
| Dec 30, 2021 | 356.31M | 167.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xbrane Biopharma AB | 208.11M |
| Elicera Therapeutics AB | 185.86M |
| Abera Bioscience AB | 161.94M |
| Simris Group AB (PUBL) | 158.60M |
| Diamyd Medical AB | 156.53M |
| Xintela AB | 138.66M |
| NextCell Pharma AB | 135.24M |
| Active Biotech AB | 115.20M |